US 8173134
ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them
granted A61KA61K45/06A61P
Quick answer
US patent 8173134 (ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them) held by Five Prime Therapeutics, Inc. expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K45/06, A61P, A61P1/02, A61P1/04